SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expression

Detalhes bibliográficos
Autor(a) principal: Berzaghi, R. [UNIFESP]
Data de Publicação: 2017
Outros Autores: Maia, V. S. C., Pereira, F. V., Melo, F. M. [UNIFESP], Guedes, M. S. [UNIFESP], Origassa, C. S. T., Scutti, J. B., Matsuo, A. L. [UNIFESP], Camara, N. O. S., Rodrigues, E. G. [UNIFESP], Travassos, L. R. [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1038/srep40585
https://repositorio.unifesp.br/handle/11600/55262
Resumo: Silencing of SOCS1 protein with shRNAi lentivirus (shR-SOCS1) led to partial reversion of the tumorigenic phenotype of B16F10-Nex2 melanoma cells. SOCS1 silencing inhibited cell migration and invasion as well as in vitro growth by cell cycle arrest at S phase with increased cell size and nuclei. Down-regulation of SOCS1 decreased the expression of epidermal growth factor receptor, Ins-R alpha, and fibroblast growth factor receptors. The present work aimed at analyzing the SOCS1 cell signaling and expression of proteins relevant to tumor development. An RNA microarray analysis of B16F10-Nex2 melanoma cells with SOCS1 silenced by shRNAi-SOCS1 was undertaken in comparison with cells transduced with the empty vector. Among 609 differentially expressed genes, c-Kit, Met and EphA3 cytokine/tyrosine-kinase (TK) receptors were down regulated. A significant decrease in the expression of TK receptors, the phosphorylation of mediators of ERK1/2 and p38 pathways and STAT3 (S727) were observed. Subcutaneous immunization with shR-SOCS1-transduced viable tumor cells rendered protection against melanoma in a syngeneic model, with decreased expression of PD-L1 and of matrix metallo-proteinases (MMPs) and CD-10 in those cells. The present work shows the role of SOCS1 in murine melanoma development and the potential of SOCS1-silenced tumor cells in raising an effective anti-melanoma immune response.
id UFSP_2a08adafb4c311407f7bf024c6d5113d
oai_identifier_str oai:repositorio.unifesp.br/:11600/55262
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expressionSilencing of SOCS1 protein with shRNAi lentivirus (shR-SOCS1) led to partial reversion of the tumorigenic phenotype of B16F10-Nex2 melanoma cells. SOCS1 silencing inhibited cell migration and invasion as well as in vitro growth by cell cycle arrest at S phase with increased cell size and nuclei. Down-regulation of SOCS1 decreased the expression of epidermal growth factor receptor, Ins-R alpha, and fibroblast growth factor receptors. The present work aimed at analyzing the SOCS1 cell signaling and expression of proteins relevant to tumor development. An RNA microarray analysis of B16F10-Nex2 melanoma cells with SOCS1 silenced by shRNAi-SOCS1 was undertaken in comparison with cells transduced with the empty vector. Among 609 differentially expressed genes, c-Kit, Met and EphA3 cytokine/tyrosine-kinase (TK) receptors were down regulated. A significant decrease in the expression of TK receptors, the phosphorylation of mediators of ERK1/2 and p38 pathways and STAT3 (S727) were observed. Subcutaneous immunization with shR-SOCS1-transduced viable tumor cells rendered protection against melanoma in a syngeneic model, with decreased expression of PD-L1 and of matrix metallo-proteinases (MMPs) and CD-10 in those cells. The present work shows the role of SOCS1 in murine melanoma development and the potential of SOCS1-silenced tumor cells in raising an effective anti-melanoma immune response.Univ Sao Paulo, Dept Microbiol Immunol & Parasitol, Expt Oncol Unit, Sao Paulo, BrazilRecepta Biopharma Sao Paulo, Sao Paulo, BrazilUniv Sao Paulo, Lab Canc Immunobiol, Sao Paulo, BrazilUniv Fed Sao Paulo, Dept Immunol, Sao Paulo, BrazilUniv Texas MD Anderson Canc Ctr, Dept Immunol, Immunotherapy Platform, Houston, TX 77030 USAUniv Fed Sao Paulo, Interdept Grp Hlth Econ Grides, Sao Paulo, SP, BrazilUniv Sao Paulo, Biomed Sci Inst 4, Immunol Dept, Sao Paulo, BrazilUniv Fed Sao Paulo, Dept Immunol, Sao Paulo, BrazilUniv Fed Sao Paulo, Interdept Grp Hlth Econ Grides, Sao Paulo, SP, BrazilWeb of ScienceState of Sao Paulo Foundation for Research Support (FAPESP)Brazilian National Council for Research and Development (CNPq)FAPESP: 2010/51423-0FAPESP: 2012/17473-6CNPq: 157559/2015-7Nature Publishing Group2020-07-17T14:03:15Z2020-07-17T14:03:15Z2017info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion-application/pdfhttp://dx.doi.org/10.1038/srep40585Scientific Reports. London, v. 7, p. -, 2017.10.1038/srep40585WOS000391664900001.pdf2045-2322https://repositorio.unifesp.br/handle/11600/55262WOS:000391664900001engScientific ReportsLondoninfo:eu-repo/semantics/openAccessBerzaghi, R. [UNIFESP]Maia, V. S. C.Pereira, F. V.Melo, F. M. [UNIFESP]Guedes, M. S. [UNIFESP]Origassa, C. S. T.Scutti, J. B.Matsuo, A. L. [UNIFESP]Camara, N. O. S.Rodrigues, E. G. [UNIFESP]Travassos, L. R. [UNIFESP]reponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-11T06:35:25Zoai:repositorio.unifesp.br/:11600/55262Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-11T06:35:25Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expression
title SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expression
spellingShingle SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expression
Berzaghi, R. [UNIFESP]
title_short SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expression
title_full SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expression
title_fullStr SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expression
title_full_unstemmed SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expression
title_sort SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expression
author Berzaghi, R. [UNIFESP]
author_facet Berzaghi, R. [UNIFESP]
Maia, V. S. C.
Pereira, F. V.
Melo, F. M. [UNIFESP]
Guedes, M. S. [UNIFESP]
Origassa, C. S. T.
Scutti, J. B.
Matsuo, A. L. [UNIFESP]
Camara, N. O. S.
Rodrigues, E. G. [UNIFESP]
Travassos, L. R. [UNIFESP]
author_role author
author2 Maia, V. S. C.
Pereira, F. V.
Melo, F. M. [UNIFESP]
Guedes, M. S. [UNIFESP]
Origassa, C. S. T.
Scutti, J. B.
Matsuo, A. L. [UNIFESP]
Camara, N. O. S.
Rodrigues, E. G. [UNIFESP]
Travassos, L. R. [UNIFESP]
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Berzaghi, R. [UNIFESP]
Maia, V. S. C.
Pereira, F. V.
Melo, F. M. [UNIFESP]
Guedes, M. S. [UNIFESP]
Origassa, C. S. T.
Scutti, J. B.
Matsuo, A. L. [UNIFESP]
Camara, N. O. S.
Rodrigues, E. G. [UNIFESP]
Travassos, L. R. [UNIFESP]
description Silencing of SOCS1 protein with shRNAi lentivirus (shR-SOCS1) led to partial reversion of the tumorigenic phenotype of B16F10-Nex2 melanoma cells. SOCS1 silencing inhibited cell migration and invasion as well as in vitro growth by cell cycle arrest at S phase with increased cell size and nuclei. Down-regulation of SOCS1 decreased the expression of epidermal growth factor receptor, Ins-R alpha, and fibroblast growth factor receptors. The present work aimed at analyzing the SOCS1 cell signaling and expression of proteins relevant to tumor development. An RNA microarray analysis of B16F10-Nex2 melanoma cells with SOCS1 silenced by shRNAi-SOCS1 was undertaken in comparison with cells transduced with the empty vector. Among 609 differentially expressed genes, c-Kit, Met and EphA3 cytokine/tyrosine-kinase (TK) receptors were down regulated. A significant decrease in the expression of TK receptors, the phosphorylation of mediators of ERK1/2 and p38 pathways and STAT3 (S727) were observed. Subcutaneous immunization with shR-SOCS1-transduced viable tumor cells rendered protection against melanoma in a syngeneic model, with decreased expression of PD-L1 and of matrix metallo-proteinases (MMPs) and CD-10 in those cells. The present work shows the role of SOCS1 in murine melanoma development and the potential of SOCS1-silenced tumor cells in raising an effective anti-melanoma immune response.
publishDate 2017
dc.date.none.fl_str_mv 2017
2020-07-17T14:03:15Z
2020-07-17T14:03:15Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1038/srep40585
Scientific Reports. London, v. 7, p. -, 2017.
10.1038/srep40585
WOS000391664900001.pdf
2045-2322
https://repositorio.unifesp.br/handle/11600/55262
WOS:000391664900001
url http://dx.doi.org/10.1038/srep40585
https://repositorio.unifesp.br/handle/11600/55262
identifier_str_mv Scientific Reports. London, v. 7, p. -, 2017.
10.1038/srep40585
WOS000391664900001.pdf
2045-2322
WOS:000391664900001
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Scientific Reports
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv -
application/pdf
dc.coverage.none.fl_str_mv London
dc.publisher.none.fl_str_mv Nature Publishing Group
publisher.none.fl_str_mv Nature Publishing Group
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268370176966656